Johnson & Johnson stock slips on Varipulse pause (JNJ:NYSE)

by


Johnson & Johnson offices in Silicon Valley

Sundry Photography/iStock Editorial via Getty Images

Sundry Photography

  • Johnson & Johnson (NYSE:JNJ) traded lower on Wednesday after the MedTech giant disclosed a temporary pause in U.S. cases treated with its Varipulse Pulsed Field Ablation Platform, which targets the cardiac disorder atrial fibrillation.
  • In reaction, its rivals in the PFA


Leave a Comment